Thousands of people in Britain are dealing with a puzzling and severe dermatological condition that has stumped doctors. Sufferers experience their skin badly inflamed, cracked and flaking, frequently across their whole body, yet many doctors have trouble diagnosing or treating the condition. The condition, called topical steroid withdrawal (TSW) or red skin syndrome, has created considerable interest on social platforms, with videos documenting patients’ experiences garnering over a billion views on TikTok alone. Although it affects a growing number of people, TSW is so little understood that some GPs and skin specialists doubt whether it exists at all. Now, for the first time, researchers across the UK are launching a large-scale study to determine what is responsible for these unexplained symptoms and why some people develop the condition whilst others do not.
The Puzzling Illness Sweeping Across the UK
Bethany Gamble’s story exemplifies the devastating impact of topical steroid withdrawal on those affected. The 21-year-old from Birmingham had controlled her eczema successfully with steroid creams since childhood, but at eighteen, her condition took a dramatic turn for the worse. Her skin became intensely inflamed and red, cracking and oozing whilst the itching became what she characterises as “bone deep”. Within two years, the pain had become so intense that she was stuck in her bed, requiring round-the-clock care from her mother. Most troubling, Bethany was repeatedly dismissed by medical professionals who attributed her symptoms to standard eczema and persistently prescribed the very treatments she suspected were triggering her suffering.
The healthcare sector continues to disagree on how to address TSW, with significant discord about its very nature. Some experts regard it as a severe allergic response to the steroid creams that serve as the primary treatment for eczema across the NHS. Others contend it amounts to a severe flare-up of pre-existing skin conditions rather than a unique syndrome, whilst a handful remain unconvinced of its existence altogether. This lack of professional consensus has put patients like Bethany trapped in a diagnostic limbo, finding it hard to obtain suitable treatment. The lack of consensus has prompted Professor Sara Brown at the University of Edinburgh to set up the first significant UK research initiative investigating TSW, supported by the National Eczema Society.
- Symptoms include severe inflammation, skin fissuring and persistent pruritus across the body
- Patients document “elephant skin” thickening and excessive flaking of keratinised cells
- Medical professionals often dismiss TSW as typical dermatitis or refuse to acknowledge it
- The condition can be so incapacitating that sufferers lack the capacity to perform daily activities
Living with Steroid Topical Withdrawal
From Manageable Eczema to Disabling Symptoms
For numerous sufferers, topical steroid withdrawal represents a catastrophic deterioration from a formerly stable skin condition. What begins as intermittent itching in skin creases can quickly progress into a widespread inflammatory reaction that renders patients incapable of functioning. The transition often occurs abruptly, unexpectedly, transforming a controllable long-term condition into an acute medical crisis. Patients report their skin turning intensely hot, red and inflamed, with severe cracking and weeping that requires constant attention. The physical toll is worsened by fatigue, as the relentless itching disrupts sleep and recovery, creating a vicious cycle of deterioration.
The rate at which TSW develops catches many sufferers off guard. Those who have dealt with eczema for years, sometimes decades, find themselves unprepared for the intensity of symptoms that emerge when their condition suddenly worsens. Simple daily activities become monumental challenges: showering becomes excruciating, dressing demands help, and preserving hygiene demands enormous effort. Some patients report feeling as though their skin is being ravaged from within, with inflammation extending over their body in patterns that show little similarity to their previous eczema flare-ups. This striking change often prompts sufferers to seek urgent medical help, only to meet with disbelief from healthcare professionals.
The Quest for Recognition
Perhaps the cruelest aspect of topical steroid withdrawal is the dismissive medical responses that frequently accompanies it. Patients experiencing serious, unexplained health issues are consistently informed they merely suffer from eczema worsening, despite their insistence that this is fundamentally different from anything they’ve encountered previously. Doctors frequently react by prescribing stronger steroids or higher dosages, potentially worsening the very condition patients suspect the topical treatments triggered. This pattern of rejection leaves sufferers experiencing abandonment by the healthcare system, forced to navigate their illness alone whilst being told their lived experience is invalid. Many patients report feeling gaslit repeatedly, their concerns dismissed as anxiety or psychological rather than genuine physiological symptoms.
The absence of medical consensus has established a significant divide between patient experience and clinical acknowledgement. Without clear diagnostic criteria or established treatment protocols, general practitioners and skin specialists find it difficult to diagnose TSW or provide suitable care. Some practitioners remain completely sceptical the condition exists, treating all severe presentations as standard eczema or recognised skin disorders. This professional uncertainty translates into diagnostic delays, unsuitable therapies and profound psychological distress for patients already suffering physically. The increased prominence of TSW on online platforms has drawn attention to this diagnostic gap, encouraging investigation to investigate what thousands of people claim to be experiencing, even as the healthcare profession remains divided on how to respond.
- Signs may develop abruptly in individuals with formerly controlled eczema treated by topical steroids
- Patients often face scepticism from medical practitioners who attribute deterioration to typical eczema exacerbations
- Healthcare providers continue to disagree on whether TSW is a real disorder or acute eczema flare-up
- Lack of diagnostic criteria means numerous patients struggle to access appropriate treatment and support
- Online platforms has magnified patient voices, with TSW hashtags accumulating over a billion views worldwide
Ethnic Inequalities in Diagnosis and Care
The diagnostic challenges surrounding topical steroid withdrawal become even more pronounced amongst individuals with darker skin, where symptoms can be considerably more difficult to recognise visually. Erythema and inflammatory responses, the hallmark signs of TSW in people with lighter skin, manifest differently across multiple populations, yet many diagnostic frameworks remain based around how the condition appears in white patients. This gap means that Black, Asian and other people of colour experiencing TSW commonly experience significantly extended timeframes in identification and acceptance. Medical staff trained chiefly via manifestations in lighter-skinned individuals may overlook or misinterpret the characteristic signs, causing further misdiagnosis and incorrect management approaches that can intensify distress.
Research into TSW has historically overlooked the lived experiences with deeper skin tones, perpetuating a cycle where their symptoms remain insufficiently documented and inadequately researched. The online discussions shaping TSW discourse have been largely shaped by individuals with lighter complexions, potentially skewing medical understanding and community understanding. As Professor Sara Brown’s pioneering British research advances, ensuring diverse representation amongst research participants will be crucial to creating genuinely comprehensive diagnostic frameworks and therapeutic strategies. Without intentional action to centre the experiences of all ethnic groups, treatment inequalities in TSW identification and care threaten to increase, leaving vulnerable populations without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Emerging Research and Care Solutions Coming to Light
Leading UK Research Project Currently Happening
Professor Sara Brown’s landmark research at the University of Edinburgh constitutes a significant milestone for TSW sufferers seeking validation and understanding. Supported by the National Eczema Society, the study has enrolled many participants across the UK to explore the biological mechanisms behind topical steroid withdrawal. By examining symptoms, saliva samples and skin biopsies, researchers seek to identify why certain individuals experience TSW whilst others using identical steroid regimens do not. This scientific scrutiny marks a important transition from dismissal to serious investigation.
The investigative group partnering with Dr Alice Burleigh from patients’ support organisation Scratch That, brings both medical knowledge and lived experience to the research. Their partnership approach recognises that patients themselves hold crucial insights into their medical conditions. Professor Brown has identified patterns in TSW that defy explanation by conventional eczema understanding, including marked “elephant skin” thickening, extreme shedding and clearly defined areas of inflammation. The study’s findings could fundamentally reshape how healthcare practitioners manage diagnosis and treatment of this disabling illness.
Available Treatments and Their Limitations
Currently, management options for TSW remain limited and commonly disappointing. Many medical practitioners continue prescribing topical steroids notwithstanding evidence indicating they could worsen symptoms in those predisposed. Some patients describe short-term improvement from emollients, antihistamines and systemic medications, though outcomes differ significantly. Dermatologists continue to disagree on best treatment approaches, with some recommending full steroid withdrawal whilst others recommend gradual tapering. This absence of agreement forces patients to navigate their treatment journeys mostly in isolation, drawing substantially on peer support networks and web-based forums for advice.
Psychological support and specialist dermatological care may provide advantages, yet access is inconsistent across the NHS. Some patients have explored alternative approaches including changes to diet, environmental controls and whole-person treatment approaches, though scientific evidence validating such approaches remains sparse. The absence of established clinical protocols means treatment decisions often depend on individual dermatologist experience and patient preference rather than research-informed standards. Until robust research produces definitive answers, TSW sufferers frequently describe feeling abandoned by conventional medicine.
- Emollients and moisturisers to maintain skin barrier function and minimise water loss
- Antihistamine medications to manage itching and related sleep disturbance during flare-ups
- Oral corticosteroids or immunosuppressants for serious presentations under specialist supervision
- Psychological counselling to tackle emotional distress and worry related to prolonged skin suffering
Testimonies of Aspiration and Perseverance
Despite the uncertainty surrounding TSW and the frequently dismissive attitudes from healthcare professionals, patients are gaining resilience in shared community and shared experience. Digital support communities have emerged as lifelines for those battling the disorder, providing validation and practical advice when traditional medicine has let them down. Many individuals affected describe the point at which they found the TSW hashtag as transformative—finally finding others with the same symptoms and realising they were not isolated in their suffering. This unified voice has proven powerful enough to prompt the initial serious research initiatives, showing that patient advocacy can advance medical understanding even when institutional structures stay unconvinced.
Bethany Gamble and people in similar situations are determined to increase visibility and campaign for appropriate acknowledgement of TSW within the healthcare sector. Their readiness to share deeply personal accounts of their struggles on online platforms has made discussions more commonplace around a disorder that numerous physicians still are unwilling to accept. These patients are not sitting idly for solutions; they are engaging in research studies, documenting their symptoms meticulously, and requiring that their testimonies be given proper consideration. Their fortitude in the midst of persistent distress and dismissive healthcare practices provides encouragement that answers may finally be within attainment, and that future patients will receive the validation and care they critically depend upon.
- Patient-led research initiatives are addressing shortcomings overlooked by traditional medical institutions and advancing knowledge of TSW
- Online communities provide emotional support, practical coping strategies, and peer validation for isolated sufferers globally
- Campaign work are gradually shifting medical perception, encouraging dermatologists to investigate rather than dismiss patient concerns
